ArticleHuman gene therapy2023

Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience.

Richa Madan Lomash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.